113 related articles for article (PubMed ID: 16368466)
1. Management of menopause-associated vasomotor symptoms: Current treatment options, challenges and future directions.
Pachman DR; Jones JM; Loprinzi CL
Int J Womens Health; 2010 Aug; 2():123-35. PubMed ID: 21072305
[TBL] [Abstract][Full Text] [Related]
2. Endogenous and Therapeutic Estrogens: Maestro Conductors of the Microenvironment of ER+ Breast Cancers.
Schuler LA; Murdoch FE
Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359625
[TBL] [Abstract][Full Text] [Related]
3. Caring for the breast cancer survivor's health and well-being.
Casey PM; Faubion SS; MacLaughlin KL; Long ME; Pruthi S
World J Clin Oncol; 2014 Oct; 5(4):693-704. PubMed ID: 25302171
[TBL] [Abstract][Full Text] [Related]
4. Postmenopausal hormone therapy: an Endocrine Society scientific statement.
Santen RJ; Allred DC; Ardoin SP; Archer DF; Boyd N; Braunstein GD; Burger HG; Colditz GA; Davis SR; Gambacciani M; Gower BA; Henderson VW; Jarjour WN; Karas RH; Kleerekoper M; Lobo RA; Manson JE; Marsden J; Martin KA; Martin L; Pinkerton JV; Rubinow DR; Teede H; Thiboutot DM; Utian WH;
J Clin Endocrinol Metab; 2010 Jul; 95(7 Suppl 1):s1-s66. PubMed ID: 20566620
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of tamoxifen and anastrozole on optic cup size in breast cancer survivors.
Eisner A; Toomey MD; Falardeau J; Samples JR; Vetto JT
Breast Cancer Res Treat; 2007 Dec; 106(2):161-70. PubMed ID: 17260092
[TBL] [Abstract][Full Text] [Related]
6. Hormone therapy for women after breast cancer: a review.
Levgur M
J Reprod Med; 2004 Jul; 49(7):510-26. PubMed ID: 15305822
[TBL] [Abstract][Full Text] [Related]
7. Increased risk of recurrence after hormone replacement therapy in breast cancer survivors.
Holmberg L; Iversen OE; Rudenstam CM; Hammar M; Kumpulainen E; Jaskiewicz J; Jassem J; Dobaczewska D; Fjosne HE; Peralta O; Arriagada R; Holmqvist M; Maenpaa J;
J Natl Cancer Inst; 2008 Apr; 100(7):475-82. PubMed ID: 18364505
[TBL] [Abstract][Full Text] [Related]
8. Menopausal hormone therapy after breast cancer: the Stockholm randomized trial.
von Schoultz E; Rutqvist LE;
J Natl Cancer Inst; 2005 Apr; 97(7):533-5. PubMed ID: 15812079
[TBL] [Abstract][Full Text] [Related]
9. Hormone replacement therapy and beyond. The clinical challenge of menopausal symptoms in breast cancer survivors.
Mortimer JE
Geriatrics; 2002 Sep; 57(9):25-31. PubMed ID: 12271826
[TBL] [Abstract][Full Text] [Related]
10. Estrogen and combined estrogen-progestogen therapy in the menopause and breast cancer.
La Vecchia C
Breast; 2004 Dec; 13(6):515-8. PubMed ID: 15563861
[TBL] [Abstract][Full Text] [Related]
11. Menopausal hormone therapy and breast cancer phenotype: does dose matter?
Garwood ER; Kumar AS; Shim V
Ann Surg Oncol; 2008 Sep; 15(9):2526-32. PubMed ID: 18618187
[TBL] [Abstract][Full Text] [Related]
12. Menopausal hormone therapy (HT) in patients with breast cancer.
Batur P; Blixen CE; Moore HC; Thacker HL; Xu M
Maturitas; 2006 Jan; 53(2):123-32. PubMed ID: 16368466
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
